Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers March 27, 2017
Pharmacy Choice - News - Over-the-Counter Drugs - March 27, 2017

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 182     Next >>     Go To Page:

12/29/16 - Botanical Drug Development; Guidance for Industry; Availability
SUMMARY: The Food and Drug Administration is announcing the availability of a guidance for industry entitled "Botanical Drug Development." This guidance describes FDA's current thinking on appropriate development plans for botanical drugs to be submitted in new drug applications and specific recommendations for submitting investigational new drug..
12/29/16 - Dannex Acquires 53.47% Stake in Ayrton Drug from Adcock Ingram Holdings
Dannex Limited, a manufacturer and distributor of pharmaceutical products, has acquired a 53.47% stake in Ayrton Drug Manufacturing Limited, a manufacturer and seller of pharmaceutical and healthcare products, from Adcock Ingram Holdings, Ltd. Dannex and Ayrton are based in Ghana. Adcock is a manufacturer, marketer and distributor of a range of hea
12/29/16 - PROVECTUS BIOPHARMACEUTICALS, INC. (OTCMKTS:PVCT) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
PROVECTUS BIOPHARMACEUTICALS, INC. (OTCMKTS:PVCT) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Item5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Ce
12/28/16 - Health & Wellness: Is your medicine cabinet healthy?
When I was younger, my friends warned me that if I drank expired cough syrup, my teeth would fall out. Today, I can proudly say my teeth remained intact, but it does bring up the question: What happens when we use expired medicine? The concept of expiration dates on medicines was introduced in 1979 by the U.S. Food and Drug Administration to help c
12/28/16 - Nutra Pharma Letter to Shareholders
Nutra Pharma Corporation, a biotechnology company marketing Nyloxin and Pet Pain-Away? in the over-the-counter pain management market, and which is also developing treatments for Multiple Sclerosis, Human Immunodeficiency Virus, Adrenomyeloneuropathy and Pain announced today that the Company s Chief Executive Officer, Rik J Deitsch, has pub
12/27/16 - Drug firms eye over-the-counter market in bid to buttress growth [Seven Days (United Arab Emirates)]
Some of Indias largest drug makers such as Sun Pharmaceuticals Industries Ltd, Dr Reddys Laboratories Ltd and Glenmark Pharmaceuticals Ltd are creating a portfolio of over-the-counter products. In India, there are a lot of regulations on prescription drugs but consumer healthcare offers a slightly more positive and open environment, especially on t
12/27/16 - New Animal Drugs for Use in Animal Feed; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications
SUMMARY: The Food and Drug Administration is amending the animal drug regulations to reflect approval of 71 supplemental new animal drug applications and 35 supplemental abbreviated new animal drug applications for revised labeling reflecting a change in marketing status from over-the-counter use to use by veterinary feed directive for...
12/27/16 - Nutra Pharma Letter to Shareholders
Nutra Pharma Corporation, a biotechnology company marketing Nyloxin and Pet Pain-Away? in the over-the-counter pain management market, and which is also developing treatments for Multiple Sclerosis, Human Immunodeficiency Virus, Adrenomyeloneuropathy and Pain announced today that the Company's Chief Executive Officer, Rik J Deitsch, has publis
12/27/16 - Oral Dosage Form New Animal Drugs; Approval of New Animal Drug Applications
SUMMARY: The Food and Drug Administration is amending the animal drug regulations to reflect approval of 43 supplemental new animal drug applications and 52 supplemental abbreviated new animal drug applications for revised labeling reflecting a change in marketing status from over-the-counter to prescription for antimicrobial drugs of importance...
2/24/17 - New Animal Drugs for Use in Animal Feed; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications
Where applicable, FDA is also withdrawing approval of those parts of the NADAs that pertain to use of these antimicrobial drugs for production indications. FOR FURTHER INFORMATION CONTACT: George K. Haibel, Center for Veterinary Medicine, Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-402-5689, george.haibel@fda.hhs.gov.
2/24/17 - New Pharmaceutical Science Study Findings Recently Were Reported by T. Nayir and Co-Researchers (Assessment of rational use of drugs and...
New Pharmaceutical Science Study Findings Recently Were Reported by T. Nayir and Co-Researchers. According to news reporting out of Mersin, Turkey, by NewsRx editors, research stated, "The concepts of' essential drugs' and' national drug policy' described by the World Health Assembly in 1975 were the first steps taken towards the rational use of dr
2/23/17 - GNW-News: Novartis drug Zykadia receives FDA Priority Review for first-line use in patients with ALK+ metastatic NSCLC (english)
Novartis International AG/ Novartis drug Zykadia receives FDA Priority Review for first-line use in patients with ALK+ metastatic NSCLC. *FDA also grants Breakthrough Therapy designation based on Phase III data in. brain* If approved in the first-line setting, Zykadia will offer previously untreated ALK+ metastatic NSCLC patients a new treatment op
2/23/17 - Novartis drug Zykadia receives FDA Priority Review for first-line use in patients with ALK+ metastatic NSCLC
Novartis today announced that the US Food and Drug Administration accepted the Company's supplemental New Drug Application for filing, and granted Priority Review for the expanded use of Zykadia as a first-line treatment for patients with metastatic non-small cell lung cancer whose tumors are anaplastic lymphoma kinase- positive as detected by
2/23/17 - PROVECTUS BIOPHARMACEUTICALS, INC. (OTCMKTS:PVCT) Files An 8-K Regulation FD Disclosure
PROVECTUS BIOPHARMACEUTICALS, INC. (OTCMKTS:PVCT) Files An 8-K Regulation FD Disclosure Item7.01. Regulation FD Disclosure. On February23, 2017, Provectus Biopharmaceuticals, Inc. (the Company) issued a press release (the Press Release) announcing the appointment of Bruce Horowitz and Dominic Rodrigues as strategic advisors to the Board of Director
2/22/17 - Global Small Caps Initiates Coverage on Nutra Pharma
Nutra Pharma Corporation, a biotechnology company developing drugs for the treatment of Multiple Sclerosis and HIV that also markets Nyloxin and Pet Pain-Away? in the over-the-counter pain management market, announced today that Global Small Caps has initiated coverage of the Company including operations and overall shareholder value.
2/21/17 - Frost & Sullivan -Sub-Sahara Africa: Increase in Western Lifestyles Leads to Dire Need for Chronic Prescription Drugs
Release date- 20022017- Local manufacture of drugs presents pharmaceutical industry with business opportunity of $40.8 billion, finds Frost& Sullivan. The growing incidence of more Western lifestyle diseases such as cardiovascular disease, cancer, diabetes and respiratory disease, in addition to infectious and parasitic illness, will present the...
2/21/17 - Otsuka Launches OATHAS Training Program for Healthy Aging Supporters; Program to support pharmacies as health information bases with strong connections to local community
Otsuka Pharmaceutical will launch OATHAS* 2 to assist pharmacies and pharmacists in supporting the health of their local communities. The unique program combines knowledge acquired from Otsuka Pharmaceutical product research and development and public awareness activities with the expertise of nonprofit organization HAP* 3 in creating local...
2/21/17 - Perrigo Company plc Announces Quarterly Dividend
Perrigo Company plc today announced that its Board of Directors declared a quarterly dividend of $0.16 per share, payable on March 21, 2017 to shareholders of record on March 3, 2017. About Perrigo Perrigo Company plc, a leading global over-the-counter consumer goods and pharmaceutical company, offers patients and customers high quality products
2/21/17 - Sale of expired drugs is criminal- Isaac Adupong [Ghana News Agency]
By Caroline Pomeyie, GNA Accra, Feb. 20, GNA- Mr. Isaac Adupong, Greater Accra Regional Chairman of the Pharmaceutical Society of Ghana has reminded health professionals that selling of expired drugs to patients was illegal and criminal transgression. Isaac Adupong, Greater Accra Regional Chairman of the Pharmaceutical Society of Ghana has reminded
2/20/17 - An Application for the Trademark "MEDA CONSUMER HEALTHCARE" Has Been Filed by Mylan
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "MEDA CONSUMER HEALTHCARE" by Mylan Inc. IP Department- Trademarks, representing Mylan. This application was made available to the public on February 07, 2017.
2/20/17 - Local drug firms captivate foreign clients with profits [Vietnam Investment Review (VIR)]
2016 was a profitable year for Vietnam's biggest pharmaceutical firms, making the lucrative industry more appealing for international groups. Vietnam's biggest publicly traded drug maker, Hau Giang Pharmaceutical JSC, made a consolidated pre-tax profit of VND756.65 billion in 2016, up 20.29 per cent on year, while its consolidated net revenue climb
2/20/17 - Pharmaceutical Label Demand to Grow Over 7% Annually Through 2020
By a News Reporter-Staff News Editor at Pharma Business Week- Global demand for labels in pharmaceutical applications is projected to increase 7.1 percent annually to 5.1 billion square meters in 2020, the fastest growth rate among major label markets. These and other trends are presented in HYPERLINK "...
2/20/17 - Sale of almost expired drugs is criminal- Isaac Adupong [Ghana News Agency]
By Caroline Pomeyie, GNA Accra, Feb. 20, GNA- Mr. Isaac Adupong, Greater Accra Regional Chairman of the Pharmaceutical Society of Ghana has reminded health professionals that selling of expired or almost expired drugs to patients was illegal and criminal transgression. Isaac Adupong, Greater Accra Regional Chairman of the Pharmaceutical Society of
2/20/17 - Smoking Cessation - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017-2018
Dublin- Research and Markets has announced the addition of the "Smoking Cessation- Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" drug pipelines to their offering. Smoking Cessation- Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017, provides comprehensive insights about the marketed drugs, drug sales,
2/20/17 - Sub-Sahara Africa: Increase in Western Lifestyles Leads to Dire Need for Chronic Prescription Drugs
Frost and Sullivan, a provider of market research and analysis, growth strategy consulting and corporate training services across multiple industries, issued the following news release:. African Pharmaceuticals Market, Forecast to 2020, part of Frost& Sullivan's Life Sciences Growth Partnership Service program, provides valuable insights for Big Ph
Articles(s): 1 - 25 of 182     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415